Prestalia FDA Approval History
FDA Approved: Yes (First approved January 21, 2015)
Brand name: Prestalia
Generic name: amlodipine besylate and perindopril arginine
Dosage form: Tablets
Company: Symplmed
Treatment for: High Blood Pressure
Prestalia (amlodipine besylate and perindopril arginine) is a calcium channel blocker and long-acting angiotensin-converting enzyme (ACE) inhibitor combination for the treatment of hypertension.
Development timeline for Prestalia
| Date | Article |
|---|---|
| Jan 22, 2015 | Approval FDA Approves Prestalia (amlodipine and perindopril) for Hypertension |
| Jun 17, 2014 | FDA Accepts New Drug Application for Symplmed’s Prestalia for the Treatment of Hypertension |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
